Key Metrics
3.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
44
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.82
5-Year SI
5-year SI
- N/A 2-year SI
- 0.85 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Rheumatology
SJR
- Q2 Rheumatology
- Q1 Orthopedics and Sports Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.17
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
0%
4 to 6 months
54%
7 to 9 months
39%
Above 9 months
7%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Rheumatoid arthritis
- Psoriatic arthritis
- Hyaluronic acid
- Ankylosing spondylitis
- Osteoporosis
- Glucosamine
- Odds ratio
- Diagnostic accuracy
- Fibromyalgia
- Axial spondyloarthritis
- Osteoarthritis
- Functional disability
- Janus kinase inhibitor
- Disease activity
- Cancer
- Scoring system
- Sarcopenia
- Systematic review
- Rheumatoid factor
- Confidence interval
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 18 |
| Article Processing Charges | USD 2300 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Musculoskeletal Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Serum transthyretin levels and disease activity in patients with primary Sjögren's syndrome.
- 1 Jan 24
- Therapeutic advances in musculoskeletal disease
-
Full paper
Cardiovascular comorbidities in psoriatic arthritis: state of the art.
- 1 Jan 24
- Therapeutic advances in musculoskeletal disease
-
Full paper
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial.
- 1 Jan 24
- Therapeutic advances in musculoskeletal disease
-
Full paper
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial.
- 1 Jan 24
- Therapeutic advances in musculoskeletal disease
-
Full paper
Automated osteoporosis classification and T-score prediction using hip radiographs via deep learning algorithm.
- 1 Jan 24
- Therapeutic Advances in Musculoskeletal Disease
-
Full paper
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.
- 1 Jan 24
- Therapeutic advances in musculoskeletal disease
Scite analysis
Powered by scite_
662 articles received 12.6k citations see all
- 312 Supporting
- 11,593 Mentioning
- 54 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 3 Corrections
- 3 Errata
- 0 Expression of Concern
FAQs
How long has Therapeutic Advances in Musculoskeletal Disease been actively publishing?
Therapeutic Advances in Musculoskeletal Disease has been in operation since 2009 till date.
What is the publishing frequency of Therapeutic Advances in Musculoskeletal Disease ?
Therapeutic Advances in Musculoskeletal Disease published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Musculoskeletal Disease publish last years ?
In 2023, Therapeutic Advances in Musculoskeletal Disease published 51 articles.
What is the eISSN & pISSN for Therapeutic Advances in Musculoskeletal Disease ?
For Therapeutic Advances in Musculoskeletal Disease,eISSN is 1759-7218 and pISSN is1759-720X.
What is Citescore for Therapeutic Advances in Musculoskeletal Disease ?
Citescore for Therapeutic Advances in Musculoskeletal Disease is 3.7.
What is H index for Therapeutic Advances in Musculoskeletal Disease ?
H index for Therapeutic Advances in Musculoskeletal Disease is 44.
What is SNIP score for Therapeutic Advances in Musculoskeletal Disease ?
SNIP score for Therapeutic Advances in Musculoskeletal Disease is 1.17.
What is the SJR for Therapeutic Advances in Musculoskeletal Disease ?
SJR for Therapeutic Advances in Musculoskeletal Disease is Q1.
Who is the publisher of Therapeutic Advances in Musculoskeletal Disease ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Musculoskeletal Disease.